These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10568193)
1. Deleted form of hepatocyte growth factor ameliorates the mortality rate of severe thermal injury in rats. Arisawa H; Yamashita Y; Ogawa H; Masunaga H; Higashio K Surgery; 1999 Nov; 126(5):925-32. PubMed ID: 10568193 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment with a deleted form of hepatocyte growth factor (dHGF) prevents the mortality of plasma-loss-induced hypovolemic shock in rats. Arisawa H; Fukui K; Imai E; Yamashita Y; Iga Y; Masunaga H Shock; 2001 Dec; 16(6):438-43. PubMed ID: 11770041 [TBL] [Abstract][Full Text] [Related]
3. A deleted form of human hepatocyte growth factor stimulates hepatic lipogenesis and lipoprotein synthesis in rats. Shiota A; Yamashita Y; Fujise N; Masunaga H; Yasuda H; Higashio K Pharmacol Res; 2000 Nov; 42(5):443-52. PubMed ID: 11023706 [TBL] [Abstract][Full Text] [Related]
4. Experimental study of the effects of deletion variant of hepatocyte growth factor on hepatic ischaemia-reperfusion injury. Ikegami T; Nishizaki T; Uchiyama H; Hashimoto K; Yanaga K; Sugimachi K Br J Surg; 2000 Jan; 87(1):59-64. PubMed ID: 10606912 [TBL] [Abstract][Full Text] [Related]
5. Deletion variant of hepatocyte growth factor prolongs allograft survival after liver transplantation in rats. Ikegami T; Nishizaki T; Uchiyama H; Kakizoe S; Yanaga K; Sugimachi K Surgery; 1999 Jun; 125(6):602-7. PubMed ID: 10372025 [TBL] [Abstract][Full Text] [Related]
6. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats. Masunaga H; Fujise N; Shiota A; Yamashita Y; Yasuda H; Higashio K J Pharm Pharmacol; 1996 Aug; 48(8):876-9. PubMed ID: 8887742 [TBL] [Abstract][Full Text] [Related]
7. A mutant of deleted variant of hepatocyte growth factor (dHGF) with alanine substitution in the N-terminal basic region has higher activity in vivo. Kinosaki M; Yamaguchi K; Yamashita Y; Uematsu Y; Aihara H; Masunaga H; Morinaga T; Higashio K Biochem Biophys Res Commun; 1999 Jan; 254(2):363-7. PubMed ID: 9918843 [TBL] [Abstract][Full Text] [Related]
8. Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effects. Uematsu Y; Fujise N; Kohsaka K; Masunaga H; Higashio K J Pharm Sci; 1999 Jan; 88(1):131-5. PubMed ID: 9874714 [TBL] [Abstract][Full Text] [Related]
9. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336 [TBL] [Abstract][Full Text] [Related]